NASHVILLE, Tenn. & CHICAGO–(BUSINESS WIRE)–July 25,
2005–Allscripts Healthcare Solutions (Nasdaq:MDRX), the leading
provider of clinical software, connectivity and information solutions
that physicians use to improve healthcare today announced that
Tennessee Oncology will implement TouchWorks(TM) Electronic Health
Record (EHR). TouchWorks will electronically connect 37 oncologists
across 30 locations and allow them to share information and
collaborate.

While there has been a great deal of attention by the federal
government on electronic records, Tennessee Oncology concluded a
number of years ago that EHRs would become the standard of care. After
a five-year study of Electronic Health Records, Tennessee Oncology
decided to partner with Allscripts because of TouchWorks ability to
support clinical trial participation and a disease management program.

“With the increasing cost of healthcare in the United States, all
of the leading oncology groups are moving to more of a disease
management focus, and this simply can’t be done effectively without an
Electronic Health Record,” said Charles McKay, MD, Chief Executive
Officer of Tennessee Oncology. “The Allscripts EHR enables our
oncologists to customize the Electronic Health Record to their
individual needs, while at the same time supporting participation in
clinical trials.”

Tennessee Oncology will be initiating an extensive clinical trial
program and the Electronic Health Record provides the group the
ability to rapidly identify appropriate patients for potential
participation. Access to this data will also enhance Tennessee
Oncology’s ability to participate in the future in pay-for-performance
initiatives.

“Tennessee Oncology is an acknowledged leader in oncology and a
key part of Allscripts specialty market focus,” said Glen Tullman,
Chief Executive Officer of Allscripts. “We expect to work closely with
Tennessee Oncology to build upon the success of TouchWorks and add
functionality unique to oncology, while at the same time enhancing our
clinical trial and disease management capabilities.”

Tennessee Oncology will integrate TouchWorks with its existing
IDX(R) Groupcast(TM) practice management solution from IDX Systems
Corporation. Allscripts and IDX share a 10-year strategic relationship
that will directly link clinical and financial information to support
operational improvements at Tennessee Oncology.

About Tennessee Oncology

Tennessee Oncology originated in 1976 as Nashville
Oncology-Hematology, PC, formed from the solo practice of Stuart
Spigel, M.D. Since then, Tennessee Oncology has become one of the
largest physician-owned oncology practices in the country. With a
focus on patient care, Tennessee Oncology has expanded its services
across 30 locations.

About Allscripts

Allscripts Healthcare Solutions (Allscripts) is the leading
provider of clinical software, connectivity and information solutions
that physicians use to improve healthcare. The Company provides unique
solutions that inform, connect, and transform healthcare. The Clinical
Solutions Group’s award-winning clinical software applications include
Electronic Health Record (EHR), e-prescribing and document imaging
solutions. Allscripts’ Physicians Interactive Group provides clinical
product education and connectivity solutions for physicians and
patients. The Company’s Medication Services Group provides medication
fulfillment services. To learn more, visit Allscripts on the Web at
www.allscripts.com.

This announcement may contain forward-looking statements about
Allscripts Healthcare Solutions that involve risks and uncertainties.
These statements are developed by combining currently available
information with Allscripts beliefs and assumptions. Forward-looking
statements do not guarantee future performance. Because Allscripts
cannot predict all of the risks and uncertainties that may affect it,
or control the ones it does predict, Allscripts’ actual results may be
materially different from the results expressed in its forward-looking
statements. For a more complete discussion of the risks, uncertainties
and assumptions that may affect Allscripts, see the Company’s 2004
Annual Report on Form 10-K, available through the Web site mainained
by the Securities and Exchange Commission at www.sec.gov.

    CONTACT: Allscripts
             Dan Michelson, 312-506-1217
             dan.michelson@allscripts.com
             or
             Tennessee Oncology
             Tim Reeves, 615-333-2481
             treeves@tnonc.com

    SOURCE: Allscripts